Field Notes, powered by KPMG, is a weekly news update on news nationally and globally from the agri-food sector.
Dr Oliver Peoples, CEO of Yield10 Bioscience reports that there are changing attitudes to the science of gene editing. The company uses metabolic engineering technologies using predictive models to facilitate gene discovery. Their ultimate goal is to help major food crops become more productive to help feed the growing population worldwide. Dr Peoples reports that the largest gains can be achieved through CRISPR genome editing in staple food and feed crops. CRISPR can be used as an advanced plant-breeding tool and unlike GMOs do not introduce new genes into the crops. Gene editing provides speed and precision, meaning improvement scan be seen quickly. Dr Peoples reports that public attitudes towards gene editing appears to be shifting and focusing on the benefits that could be provided by the technology.
© 2020 KPMG, a New Zealand Partnership and a member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative (“KPMG International”), a Swiss entity. All rights reserved.
KPMG International Cooperative (“KPMG International”) is a Swiss entity. Member firms of the KPMG network of independent firms are affiliated with KPMG International. KPMG International provides no client services. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm.